I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
C series
—
12.8.2024
(Appeal - Competition - Pharmaceutical products - Market for perindopril - Article 101 TFEU - Agreements, decisions and concerted practices - Potential competition - Restriction of competition by object - Strategy to delay the market entry of generic versions of perindopril - Patent dispute settlement agreement)
(C/2024/4821)
Language of the case: English
Appellant: Lupin Ltd (represented initially by M. Hoskins KC, V. Wakefield KC, S. Smith and A. White, Solicitors, and subsequently by B. Bär-Bouyssière, avocat, M. Hoskins KC, V. Wakefield KC, A. Politis, avocat, S. Smith and A. White, Solicitors)
Other party to the proceedings: European Commission (represented initially by F. Castilla Contreras, B. Mongin and C. Vollrath, acting as Agents, and by B. Rayment, Barrister-at-Law, and subsequently by F. Castilla Contreras and C. Vollrath, acting as Agents, and by B. Rayment, Barrister-at-Law)
Intervener in support of the other party: United Kingdom of Great Britain and Northern Ireland (represented initially by D. Guðmundsdóttir, acting as Agent, and subsequently by S. Fuller, acting as Agent)
The Court:
1.Dismisses the appeal;
2.Orders Lupin Ltd to bear its own costs and to pay those incurred by the European Commission;
3.Orders the United Kingdom of Great Britain and Northern Ireland to bear its own costs.
—
Language of the case: English.
ELI: http://data.europa.eu/eli/C/2024/4821/oj
ISSN 1977-091X (electronic edition)
—